Suboxone Film, Soluble
Product Images NDC 12496-1202
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Suboxone (NDC 12496-1202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Indivior Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Sub01 0035 02
Sub01 0035 03
Sub01 0035 04
Sub01 0035 05
Sub01 0035 06
Sub01 0035 07
Sub01 0035 08
Sub01 0035 09
Sub01 0035 10
This is a medication instruction for Suboxone, which is a combination medicine used to treat opioid addiction. It is available in the form of sublingual film in 4 mg/1 mg strength. The text provides dosage instructions, administration techniques and warnings about accidental ingestion by children. It also asks the pharmacist to dispense the medication guide alongside the product.*
Sub01 0035 11
Sub01 0035 12
Sub01 0035 13
Sub01 0035 14
Suboxone is a medication that contains buprenorphine and naloxone in a ratio of 12 mg/3 mg per sublingual film. It comes in a pack of 30 pouches, each containing one film. The instructions for the pharmacist include dispensing the enclosed Medication Guide. The medication is only for oral consumption and should not be cut or chewed. In case of accidental intake by children, emergency medical care is required. The trademark for Suboxone is registered to Indivir UK Limited.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.